Bauer R, Haluszczynski I, Langhammer H, Bachmann W
Eur J Nucl Med. 1983;8(5):218-22. doi: 10.1007/BF00253769.
Red blood cells (RBC) were labeled with 99mTc in vitro after in vivo pretreatment with a stannous solution. The whole in vivo/in vitro procedure took 30-40 min. Pretinning was carried out by injection of either 6 mg DTPA and 0.6 mg Sn++ (Sn-DTPA) or 5 mg pyrophosphate and 0.7 mg Sn++ (Sn-PYP). The results of 1,356 patients were evaluated. The labeling yield was 89.7% (mean) after pretinning with Sn-DTPA and 88.2% following Sn-PYP pretreatment, the median values being 94% and 92%, respectively. The new method was successfully used in over 2,000 patients who had a radionuclide-ventriculography and in 38 patients studied for localization of occult gastrointestinal bleeding. Adverse side effects have never been observed.
红细胞(RBC)在体内用亚锡溶液预处理后,于体外进行99mTc标记。整个体内/体外操作过程耗时30 - 40分钟。预锡化通过注射6毫克二乙三胺五乙酸(DTPA)和0.6毫克二价锡(Sn++)(Sn - DTPA)或5毫克焦磷酸盐和0.7毫克二价锡(Sn++)(Sn - PYP)来进行。对1356例患者的结果进行了评估。用Sn - DTPA预锡化后标记率平均为89.7%,用Sn - PYP预处理后为88.2%,中位数分别为94%和92%。该新方法成功应用于2000多名接受放射性核素心室造影的患者以及38例用于隐匿性胃肠道出血定位研究的患者。从未观察到不良反应。